104 related articles for article (PubMed ID: 11134797)
1. Combined analysis of autoantibodies against beta-cells for prediction of pancreas allograft failure.
Da Silva M; Thivolet C; Lefrançois N; Bosshard S; Sepeteanu I; Petruzzo P; Dubernard JM; Martin X
Transplant Proc; 2000 Dec; 32(8):2773. PubMed ID: 11134797
[No Abstract] [Full Text] [Related]
2. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
Bonifacio E; Bingley PJ
Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
[No Abstract] [Full Text] [Related]
3. Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation.
Lohmann T; Klemm T; Geissler F; Uhlmann D; Ludwig S; Hauss J; Witzigmann H
Transplant Proc; 2002 Sep; 34(6):2249-50. PubMed ID: 12270385
[No Abstract] [Full Text] [Related]
4. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
[TBL] [Abstract][Full Text] [Related]
5. Retrospective assessment of islet cell autoantibodies in pancreas organ donors.
Diamantopoulos S; Allende G; Ferreira JM; Ciancio G; Burke GW; Pugliese A
Diabetes Care; 2008 Sep; 31(9):1741-2. PubMed ID: 18556338
[TBL] [Abstract][Full Text] [Related]
6. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y
Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
[No Abstract] [Full Text] [Related]
7. Proposed guidelines on screening for risk of type 1 diabetes.
Bingley PJ; Bonifacio E; Ziegler AG; Schatz DA; Atkinson MA; Eisenbarth GS;
Diabetes Care; 2001 Feb; 24(2):398. PubMed ID: 11213898
[No Abstract] [Full Text] [Related]
8. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
Thivolet C
Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
[No Abstract] [Full Text] [Related]
9. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
[No Abstract] [Full Text] [Related]
10. Combined antibody screening for improved prediction of IDDM--modern strategies.
Roll U; Ziegler AG
Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
[No Abstract] [Full Text] [Related]
11. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
[No Abstract] [Full Text] [Related]
12. Selecting culprits in type 1 diabetes beta-cell killing.
Lernmark A
J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509
[No Abstract] [Full Text] [Related]
13. Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies.
Lernmark A; Kolb H; Mire-Sluis T
Diabetologia; 1999 Mar; 42(3):381-2. PubMed ID: 10096794
[No Abstract] [Full Text] [Related]
14. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
Fukui M; Nakamura N; Nakano K; Kondo M
Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
[No Abstract] [Full Text] [Related]
15. A diabetes potpourri, Part 1.
Bloomgarden ZT
Diabetes Care; 1995 May; 18(5):734-6. PubMed ID: 8586018
[No Abstract] [Full Text] [Related]
16. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.
Braghi S; Bonifacio E; Secchi A; Di Carlo V; Pozza G; Bosi E
Diabetes; 2000 Feb; 49(2):218-24. PubMed ID: 10868938
[TBL] [Abstract][Full Text] [Related]
17. Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation.
Thivolet C; Abou-Amara S; Martin X; Lefrancois N; Petruzzo P; McGregor B; Bosshard S; Dubernard JM
Transplantation; 2000 Jan; 69(1):99-103. PubMed ID: 10653387
[TBL] [Abstract][Full Text] [Related]
18. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
Costa A; Conget I; Casamitjana R
Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
[No Abstract] [Full Text] [Related]
19. [Autoantibodies in type 1 diabetes mellitus].
Ziegler M; Ziegler B
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
[No Abstract] [Full Text] [Related]
20. Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.
Mujtaba MA; Fridell J; Book B; Faiz S; Sharfuddin A; Wiebke E; Rigby M; Taber T
Clin Transplant; 2015 Nov; 29(11):991-6. PubMed ID: 26289931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
